DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ng SC, Hilmi IN, Blake A. et al
Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting.
Inflamm Bowel Dis 2018;
24: 2431-2441 . doi:10.1093/ibd/izy153
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.